Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleM0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
- Where
- New Haven, New York, San Antonio
- Age
- 18 years and over
- People
- 77 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07166601 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Where
- Arlington Heights, Aurora, Charlottesville, Chicago, Columbus, Dallas, Detroit, Edmonds, Fairfax, Fullerton, Houston, Lake Success, Los Angeles, New York, Orange, Philadelphia, Sacramento, San Francisco, Vallejo, Winchester
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- ArriVent BioPharma, Inc.
See details and how to joinNCT07185997 - Phase 3Taking peopleBeamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
- Where
- Abilene, Amarillo, Atlanta, Boise, Boston, Charlotte, Chicago, Durham, Fairfax, Fresno, Glendale, Houston, Lisle, Marietta, New York, Ogden, Orange, Orange City, Portland, Reno, Roseville, San Francisco, Santa Monica, Vallejo, Washington D.C.
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07195695 · EU 2025-521284-12-00 - Phase 3Taking peopleA Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
- Where
- Fair Oaks, Fountain Valley, Houston, Jonesboro, Knoxville, Los Alamitos, Margate, New York, Springfield, Tamarac, Torrance, Washington D.C.
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Takeda
See details and how to joinNCT07217301 · EU 2026-525659-94-00 - Phase 2Taking peopleA Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)
- Where
- Reno
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Puma Biotechnology, Inc.
See details and how to joinNCT07465757 · EU 2026-525382-47-00 - Phase 3Taking peopleEvaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
- Where
- Ann Arbor, Aurora, Duarte, Houston, Newport Beach, Orlando, Philadelphia, Rochester
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Vergent Bioscience, Inc.
See details and how to joinNCT07499674 - Phase 2Taking peopleUniversal Immunization to Fortify Immunotherapy Efficacy and Response
- Where
- Gainesville
- Age
- 18 years and over
- People
- 500
- Run by
- University of Florida
See details and how to joinNCT07597070 - Early phase 1Taking peoplePilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients
- Where
- Phildelphia
- Age
- 12 years to 17 years
- People
- 20
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT07658768 - Phase 1Taking peopleA Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
- Where
- Houston, Miami
- Age
- 18 years and over
- People
- 152
- Run by
- Aktis Oncology, Inc.
See details and how to joinNCT07887971 - Phase 1/2Taking peopleCR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Austin, Dallas, Fairfax
- Age
- 18 years and over
- People
- 219
- Run by
- Crescent Biopharma, Inc.
See details and how to joinNCT07909031 · EU 2026-527289-54-00 - Phase 1Not yet taking people in United StatesA Phase 1 Trial of KAN-001 With Pembrolizumab, With or Without Chemotherapy, in Participants With PD-L1-Positive Non-Small Cell Lung Cancer
- Where
- Maumee
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Kanvas Biosciences
See details and how to joinNCT07910942 - Phase 2Taking peopleCabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 86
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT01639508 - Phase 2Taking peopleAdministration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 285
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03412877 - Phase 2Taking peopleAdjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
- Where
- Stanford
- Age
- 18 years and over
- People
- 80
- Run by
- Stanford University
See details and how to joinNCT04585477 - Phase 2/3Taking peoplePhase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Where
- Abilene, Albany, Alexandria, Allentown, Amarillo, Anaheim, Arlington, Arlington Heights, Athens, Atlanta, Aurora, Austin, Aventura, Baltimore, Baton Rouge, Bay Pines, Bedford, Belleville, Bonita Springs, Boston, Boulder, Bradenton, Brighton, Burnsville, Cape Coral, Carrollton, Cartersville, Celebration, Centennial, Cerritos, Chanute, Charleston, Chicago, Cincinnati, Cleveland, Colorado Springs, Columbus, Covington, Dallas, Daytona Beach, Denison, Denver, Dickson, Douglasville, Durham, East Brunswick, Edina, El Dorado, El Paso, Eugene, Fairfax, Fairfield, Fleming Island, Fort Myers, Fountain Valley, Foxborough, Franklin, Fredericksburg, Gainesville, Gallatin, Germantown, Goodyear, Goshen, Grand Island, Hackensack, Hendersonville, Hermitage, Hiram, Honolulu, Houston, Huntington, Independence, Irving, Jackson, Jacksonville, Jacksonville Beach, Kettering, Kingman, Laguna Hills, Lakewood, Las Vegas, Lebanon, Leesburg, Lexington, Liberal, Littleton, Lone Tree, Long Beach, Longmont, Longview, Los Alamitos, Los Angeles, Louisville, Macon, Madison, Marietta, Massillon, Maywood, McPherson, Merriam, Methuen, Miami, Midland, Milford, Minneapolis, Murfreesboro, Naples, Nashville, Newton, Niles, Norwich, Odessa, Omaha, Orlando, Papillion, Park Ridge, Parsons, Pensacola, Peoria, Pittsburgh, Port Charlotte, Portland, Pratt, Prescott Valley, Providence, Pueblo, Rancho Mirage, Rhinebeck, Richmond, Rochester, Safford, Saint Augustine, Salem, Salina, Salt Lake City, San Francisco, Santa Ana, Santa Rosa, Sarasota, Shelbyville, Sioux Falls, Smyrna, Somerset, South Weymouth, Spartanburg, Springdale, Stockton, Stuart, Tallahassee, Tampa, Teaneck, The Bronx, The Woodlands, Thornton, Tigard, Tucson, Tyler, Vancouver, Venice, Vero Beach, Washington D.C., Wellington, Weston, West Palm Beach, Westwood, Whittier, Wichita, Wichita Falls, Winfield
- Age
- 18 years and over
- People
- 626 worldwide
- Run by
- Mirati Therapeutics Inc.
See details and how to joinNCT04613596 · EU 2023-508922-83-00 - No phaseTaking peopleTumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 5
- Run by
- Mayo Clinic
See details and how to joinNCT05746325 - No phaseTaking peopleReal World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
- Where
- Canton, Chapel Hill, Cleveland, Durham, Evanston, Massillon, New Haven
- Age
- 18 years and over
- People
- 25
- Run by
- Carevive Systems, Inc.
See details and how to joinNCT05974150 - Phase 1/2Taking peopleFirst-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- Where
- Charlotte, Duarte, Fairfax, Houston, Huntington Beach, Irvine, Nashville, Philadelphia, Salt Lake City
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06043817 · EU 2023-506759-51-00 - Phase 1Taking peopleStudy of XB010 in Subjects With Solid Tumors
- Where
- Atlanta, Austin, Chicago, Dallas, Fairfax, Houston, Huntersville, Irvine, Los Angeles, Nashville, Oklahoma City, Orlando, St Louis, The Bronx, Washington D.C.
- Age
- 18 years and over
- People
- 396 worldwide
- Run by
- Exelixis
See details and how to joinNCT06545331 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 15,000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - Phase 1/2Taking peopleKEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Where
- Baltimore, Boston, Cleveland, Columbus, Duarte, Fargo, Gilbert, Hackensack, Houston, Lebanon, Lexington, New York, Omaha, Philadelphia, San Francisco, Sioux Falls, Washington D.C.
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04165070 · EU 2023-506932-33-00 - No phaseTaking peopleKEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Where
- Baltimore, Boston, Cleveland, Columbus, Duarte, Fargo, Gilbert, Hackensack, Houston, Lebanon, Lexington, New York, Omaha, Philadelphia, San Francisco, Sioux Falls, Washington D.C.
- Age
- 18 years and over
- People
- 1,065 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04165798 - Phase 3Taking peopleA Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Where
- Aberdeen, Austin, Billings, Birmingham, Boston, Brooklyn, Chandler, Charleston, Chesterfield, Duarte, East Brunswick, Elmhurst, Farmington, Goshen, Greenville, Hattiesburg, Hendersonville, Honolulu, Huntington Beach, Indianapolis, Irvine, Jacksonville, Kansas City, Lake Success, Lancaster, Lexington, Lincoln, Los Angeles, Memphis, Ocala, Ogden, Phoenix, Pinehurst, Rancho Mirage, Reno, Renton, Rochester, Santa Monica, Savannah, Sioux Falls, Spokane, Springfield, St Louis, Tamarac, York, Ypsilanti, Yuma, Zanesville
- Age
- 18 years and over
- People
- 768 worldwide
- Run by
- AbbVie
See details and how to joinNCT04928846 · EU 2023-505749-14-00 - Phase 1/2Taking peopleStudy of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- Where
- Atlanta, Baltimore, Beverly Hills, Boston, Chicago, Cleveland, Columbus, Durham, El Paso, Fairfax, Fullerton, Houston, Jacksonville, La Jolla, Lake Success, Los Angeles, Memphis, Nashville, New Haven, Newport Beach, New York, Philadelphia, Pittsburgh, Portland, Rochester, Saint Paul, Santa Monica, Tacoma, The Woodlands, Tucson, Washington D.C.
- Age
- 18 years and over
- People
- 364 worldwide
- Run by
- Synthekine
See details and how to joinNCT05098132 · EU 2025-522632-14-00 - Phase 1/2Taking peopleTesting the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Where
- Atlanta, Baltimore, Basking Ridge, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Commack, Concord, Crown Point, Duarte, Fairway, Gainesville, Harrison, Hartford, Irvine, Kansas City, La Jolla, Lexington, Middletown, Montvale, New Haven, New Lenox, New York, North Haven, Orland Park, Overland Park, Pittsburgh, Richmond, Sacramento, Stamford, Tampa, Trumbull, Uniondale, Washington D.C., West Chester, Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 45
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06287775